NONO expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.698960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.860200E-02
Normal-vs-Stage2
1.827560E-01
Normal-vs-Stage3
1.418570E-01
Normal-vs-Stage4
3.723400E-01
Stage1-vs-Stage2
7.679000E-01
Stage1-vs-Stage3
2.647000E-01
Stage1-vs-Stage4
9.890800E-01
Stage2-vs-Stage3
2.797200E-01
Stage2-vs-Stage4
8.221600E-01
Stage3-vs-Stage4
4.596400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.874570E-01
Normal-vs-AfricanAmerican
1.820570E-01
Normal-vs-Asian
8.776400E-02
Caucasian-vs-AfricanAmerican
8.894800E-01
Caucasian-vs-Asian
3.487400E-01
AfricanAmerican-vs-Asian
4.542000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.866440E-01
Normal-vs-Female
1.570010E-01
Male-vs-Female
8.110200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.613800E-01
Normal-vs-Age(41-60Yrs)
4.662200E-01
Normal-vs-Age(61-80Yrs)
8.099700E-02
Normal-vs-Age(81-100Yrs)
1.243200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.892200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.079800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.912200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.158400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.390400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.127600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.176400E-02
Normal-vs-Daily Drinker
1.386950E-01
Normal-vs-Weekly Drinker
4.324400E-01
Normal-vs-Occasional Drinker
6.823800E-01
Normal-vs-Social Drinker
2.142800E-01
Non Drinker-vs-Daily Drinker
9.036600E-01
Non Drinker-vs-Weekly Drinker
3.236800E-01
Non Drinker-vs-Occasional Drinker
2.341600E-02
Non Drinker-vs-Social Drinker
1.756790E-01
Daily Drinker-vs-Weekly Drinker
4.345800E-01
Daily Drinker-vs-Occasional Drinker
5.719600E-02
Daily Drinker-vs-Social Drinker
2.755800E-01
Weekly Drinker-vs-Occasional Drinker
4.118000E-01
Weekly Drinker-vs-Social Drinker
9.256800E-01
Occasional Drinker-vs-Social Drinker
3.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.282200E-01
Normal-vs-Grade 2
9.446800E-01
Normal-vs-Grade 3
9.945000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.747600E-01
Grade 1-vs-Grade 3
1.136040E-01
Grade 1-vs-Grade 4
9.282200E-01
Grade 2-vs-Grade 3
7.325900E-02
Grade 2-vs-Grade 4
9.446800E-01
Grade 3-vs-Grade 4
9.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.513600E-02
Normal-vs-NonDiabetic
2.173400E-01
Diabetic-vs-NonDiabetic
1.363020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.925210E-01
Normal-vs-NoPancreatitis
1.867370E-01
Pancreatitis-vs-NoPancreatitis
7.150400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.666400E-02
Normal-vs-N1
2.066800E-01
N0-vs-N1
9.215000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.381600E-01
Normal-vs-TP53-NonMutant
2.644200E-01
TP53-Mutant-vs-TP53-NonMutant
6.756200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
